MedTrace Logo

SMARTHealth Diabetes in China Using Lay Family Health Promoters

NCT02726100 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2073

Last updated 2021-03-12

No results posted yet for this study

Summary

It's a community-based parallel-arm cluster Randomized Controlled Trial (RCT). An interactive mobile health management system will be developed to support lay family health promoters and healthcare staff to improve clinical outcomes for family members with Type 2 Diabetes Mellitus (T2DM). 2,000 participants from 80 sites will be chosen from urban (40 communities) and rural (40 villages) settings in Shijiazhuang City, Hebei Province.

Conditions

Interventions

BEHAVIORAL

SMARTHealth Diabetes

SMARTHealth Diabetes is an interactive mobile health platform to promote improved self-management for people with T2DM.

Sponsors & Collaborators

  • Global Alliance for Chronic Diseases (GACD)

    collaborator OTHER

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • The George Institute for Global Health, China

    lead OTHER

Principal Investigators

  • Puhong Zhang, PhD · The George Institute for Global Health at Peking University Health Science Center

  • David Peiris, PhD · The George Institute for Global Health, University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2019-10-19
Completion
2021-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02726100 on ClinicalTrials.gov